Zhang Xing, Hu Yangyang, Wang Wei, Ji Ru, Li Ziyue, Yu Weiyan, Wu Zhinian, Xiao Ying, Guo Tingyu, Qi Zeqiang, Wang Yadong, Zhao Caiyan
Department of Infectious Diseases, the Hebei Medical University Third Hospital, Shijiazhuang, 050051, China.
Cell Death Discov. 2024 Jun 7;10(1):272. doi: 10.1038/s41420-024-02052-w.
Immune-related GTPase M (IRGM) induces autophagy and suppresses inflammation, but its putative role and signaling mechanism remain undefined in the pathogenesis of liver failure. This study aimed to address how IRGM attenuates inflammatory injury by regulating autophagy in liver failure. In this study, a total of 10 patients with hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) and 10 healthy controls were prospectively enrolled. Intrahepatic expression of IRGM/Irgm1, NLRP3 inflammasome (NLRP3, ASC, and caspase-1), autophagy-related proteins (LC3II, P62), and inflammatory cytokines (IL-1β, TNF-α) were measured. Autophagy was activated by rapamycin (4 mg/kg) in an acute liver failure (ALF) mouse model, which was used to further study the expression of Irgm1, NLRP3 inflammasome, autophagy-related proteins, and inflammatory cytokines using both qRT-PCR and Western blot analyses. Irgm1 expression was knocked down using Irgm1 short hairpin RNA (shRNA) in lipopolysaccharide (LPS)-induced AML12 cells to investigate the effects of Irgm1 deletion on autophagy and inflammation. We found that the expression of IRGM and autophagy-related proteins was significantly downregulated while the NLRP3 inflammasome was significantly upregulated in the livers of HBV-ACLF patients and the ALF mouse model (all P < 0.05). Rapamycin-induced autophagy ameliorated intrahepatic NLRP3 inflammasome activation and decreased inflammation and necrosis in the ALF mice. Irgm1 knockdown decreased autophagy and significantly upregulated NLRP3 inflammasome activation in AML12 cells (all P < 0.05). Rapamycin-induced autophagy also protected against hepatocyte injury following LPS stimulation in vitro by inhibiting NLRP3 inflammasome activation. Thus, IRGM/Irgm1 alleviates inflammation-mediated hepatocyte injury by regulating autophagy. This study provides new insight into potential molecular targets to treat liver failure.
免疫相关GTP酶M(IRGM)可诱导自噬并抑制炎症,但在肝衰竭发病机制中其假定作用和信号传导机制仍不明确。本研究旨在探讨IRGM如何通过调节肝衰竭中的自噬来减轻炎症损伤。本研究前瞻性纳入了10例乙型肝炎病毒相关慢加急性肝衰竭(HBV-ACLF)患者和10名健康对照者。检测肝内IRGM/Irgm1、NLRP3炎性小体(NLRP3、ASC和半胱天冬酶-1)、自噬相关蛋白(LC3II、P62)和炎性细胞因子(IL-1β、TNF-α)的表达。在急性肝衰竭(ALF)小鼠模型中用雷帕霉素(4mg/kg)激活自噬,并用qRT-PCR和蛋白质印迹分析进一步研究Irgm1、NLRP3炎性小体、自噬相关蛋白和炎性细胞因子的表达。在脂多糖(LPS)诱导的AML12细胞中用Irgm1短发夹RNA(shRNA)敲低Irgm1表达,以研究Irgm1缺失对自噬和炎症的影响。我们发现,在HBV-ACLF患者肝脏和ALF小鼠模型中,IRGM和自噬相关蛋白的表达显著下调,而NLRP3炎性小体显著上调(均P<0.05)。雷帕霉素诱导的自噬改善了肝内NLRP3炎性小体激活,并减少了ALF小鼠的炎症和坏死。Irgm1敲低降低了自噬,并显著上调了AML12细胞中NLRP3炎性小体激活(均P<0.05)。雷帕霉素诱导的自噬还通过抑制NLRP3炎性小体激活在体外保护肝细胞免受LPS刺激后的损伤。因此,IRGM/Irgm1通过调节自噬减轻炎症介导的肝细胞损伤。本研究为治疗肝衰竭的潜在分子靶点提供了新的见解。